S. 1133 · 117th Congress · Senate

Cardiovascular Advances in Research and Opportunities Legacy Act

Active· Read twice and referred to the Committee on Health, Education, Labor, and Pensions. (Sponsor introductory remarks on measure: CR S1984; text…
Introduced
Apr 15, 21
Passed Senate
Pending
Passed House
Pending
Sent to President
Pending
Signed into Law
Pending

Executive Summary

Cardiovascular Advances in Research and Opportunities Legacy Act

This bill expands research on valvular heart disease and its treatment. This disease is caused by damage to or disease affecting any valve that controls blood flow in the heart.

The National Institutes of Health must consult with the National Heart, Lung, and Blood Institute to conduct or support research on the disease, including on mitral valve prolapse. This occurs when the valve between the chambers of the left side of the heart seals improperly.

The Centers for Disease Control and Prevention (CDC) must develop best practices to treat valvular heart disease. The CDC may also carry out other projects to increase awareness of and reduce deaths from the disease.

Action Timeline

2
  1. APR 15, 2021IntroReferral

    Introduced in Senate

  2. APR 15, 2021IntroReferral

    Read twice and referred to the Committee on Health, Education, Labor, and Pensions. (Sponsor introductory remarks on measure: CR S1984; text: CR S1985)

Committees

1

Health, Education, Labor, and Pensions Committee

sshr00

Referred: Apr 15, 2021

Active